Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient
Authors:
- 7 August 2010
- journal article
- case report
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 14 (6) , 637-640
Abstract
A 27-year-old woman underwent living kidney transplantation from her mother. She received basiliximab, tacrolimus, mycophenolate mofetil (MMF), and a corticosteroid. Before transplantation, her complete blood count and white cell differential were normal. On about the 70th postoperative day (POD 70), her white blood cell (WBC) count began to decrease. On POD 113, her WBC count was 2800/μL. There was no evidence of viral infection, other systemic infection or malignancy. Drug-induced neutropenia, especially MMF-induced neutropenia, was suspected, and the dosage of MMF was reduced. However, the neutrophil count fell to 0/μL within 2 weeks. We further reduced the dosage of MMF and administered granulocyte-colony stimulating factor (G-CSF), which only temporarily increased the neutrophil count. Then, MMF was discontinued and switched to azathioprine, resulting in recovery of neutrophil count without subsequent rejection. MMF-induced neutropenia frequently occurs and should be monitored not only by WBC count but also by white cell differential count, since early discontinuation is the key to successful resolution of neutropenia. Switching from MMF to azathioprine or administration of G-CSF with or without MMF discontinuation might be options for treatment to avoid subsequent rejection.Keywords
This publication has 11 references indexed in Scilit:
- Incidence, Risk Factors and Clinical Consequences of Neutropenia Following Kidney Transplantation: A Retrospective StudyAmerican Journal of Transplantation, 2009
- Leukopenia in Kidney Transplant Patients With the Association of Valganciclovir and Mycophenolate MofetilTransplantation Proceedings, 2008
- Correlation Between Body Mass Index and Leucopenia After Administration of Valganciclovir for Cytomegalovirus Infection in Chinese Cardiac RecipientsCirculation Journal, 2007
- Rabbit Antithymocyte Globulin versus Basiliximab in Renal TransplantationNew England Journal of Medicine, 2006
- Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipientsNephrology Dialysis Transplantation, 2006
- Mycophenolate Mofetil–Induced Neutropenia in Liver TransplantationTransplantation Proceedings, 2005
- Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantationKidney International, 2002
- Correlation of Mycophenolic Acid Pharmacokinetic Parameters with Side Effects in Kidney Transplant Patients Treated with Mycophenolate MofetilClinical Chemistry, 2001
- NEUTROPHIL DYSPLASIA CAUSED BY MYCOPHENOLATE MOFETILTransplantation, 2000
- The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function*Clinical Pharmacology & Therapeutics, 1998